IGROV1 NTCC®人源卵巢癌细胞株human ovarian carcinoma cell line-BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

IGROV1 NTCC®人源卵巢癌细胞株human ovarian carcinoma cell line-BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

IGROV1 is a human ovarian carcinoma cell line commonly used in cancer research. It's particularly valuable for studying:

• Ovarian cancer biology: Understanding the molecular mechanisms underlying ovarian cancer development and progression.

• Drug resistance: Investigating how ovarian cancer cells develop resistance to chemotherapy drugs.

• Drug discovery and development: Screening potential anticancer drugs and evaluating their efficacy against ovarian cancer cells.

• Tumor microenvironment: Studying the interactions between tumor cells and the surrounding host tissue.

Key characteristics of IGROV1 cells:

• Drug resistance: Relatively resistant to many chemotherapeutic agents, making it a useful model for studying drug resistance mechanisms.

• Tumorigenic: Can form tumors when injected into animals, allowing researchers to study tumor growth and metastasis.

• Well-characterized: Its genetic and phenotypic properties are well-documented.

By studying IGROV1 cells, researchers can gain valuable insights into the biology of ovarian cancer and develop more effective treatments for patients with this disease.

生产厂家Supplier:

BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

E-mail:BioVector@163.com

http://www.biovector.net